-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Proteomic Health in Hematopoietic Stem Cells

Program: Scientific Program
Session: JOINT SESSION: The Fuel & Physiology of Regeneration
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acquired Marrow Failure Syndromes, Acute Myeloid Malignancies, AML, Translational Research, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, CHIP, Hematopoiesis, Diseases, Myeloid Malignancies, Biological Processes
Saturday, December 7, 2024, 4:00 PM-5:35 PM

Robert Signer, PhD

University of California San Diego, La Jolla, CA

Disclosures: Signer: Exact Sciences: Current equity holder in publicly-traded company, Other: Spouse employment; Vir: Current equity holder in publicly-traded company; Syndax: Current equity holder in publicly-traded company; Illumina: Current equity holder in publicly-traded company.

Previous Presentation | Next Presentation >>